
Moderna (MRNA) has had the highest return since January 1, 2026 and this year by a large-cap US stock, returning 553.7%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 553.7% |
Sandisk (SNDK) | 159.43% |
Frontline (FRO) | 144.96% |
Marathon Petroleum (MPC) | 128.73% |
Okta (OKTA) | 119.69% |
Dell Technologies (DELL) | 118.81% |
Valero Energy (VLO) | 107.73% |
Glaukos (GKOS) | 107.31% |
Micron Technology (MU) | 101.59% |
Revolution Medicines (RVMD) | 100.77% |
HF Sinclair (DINO) | 95.44% |
Advanced Micro Devices (AMD) | 93.87% |
Crowdstrike (CRWD) | 93.62% |
Phillips 66 (PSX) | 90.38% |
SharkNinja (SN) | 89.62% |
APA (APA) | 88.44% |
Palo Alto Networks (PANW) | 85.77% |
Royalty Pharma (RPRX) | 79.94% |
Roivant Sciences (ROIV) | 78.05% |
Life Time (LTH) | 75.49% |
Target (TGT) | 75.26% |
Equinor ASA ADR (EQNR) | 71.65% |
Hewlett Packard Enterprise (HPE) | 70.51% |
BrightSpring Health Services, Inc Common Stock (BTSG) | 67.48% |
Virtu Financial (VIRT) | 67.02% |
Large-cap stocks are treated as having a market cap of $10B+.